Effect of Systemic Antibiotic Therapy on Postoperative Complications in Patients Undergoing Wisdom Teeth Removal Surgery.
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
59 medically healthy patients, who are scheduled for third molar extraction surgery and give
informed consent for the trial, are operated using a split-mouth technique.
One group of patients will be assigned to the test group (Amoxilan) for the first surgery and
to the control group (placebo) for the second surgery, and vice versa, according to
randomisation.
Patients receive 8 capsules Amoxilan or placebo (according to randomisation) perioperatively,
and 6 capsules Amoxilan/placebo per day for 3 days postoperativeley.